Else Nutrition Q3 gross margin rises to 34% on cost optimization

Else Nutrition Holdings

14/11/2025 12:53

Overview

Else Nutrition Q3 gross margin rises to 34% from negative 9% in Q3 2024

Operating expenses decreased 68% yr/yr, totaling C$1.15 mln in Q3 2025

Revenue stable at C$1.66 mln, slightly down from $1.79 mln in Q3 2024

Outlook

Else Nutrition expects continued operational improvements in Q4

Company is preparing for next clinical phase of plant-based infant formula

Else Nutrition focuses on resolving supply chain challenges and expanding presence

Result Drivers

GROSS MARGIN EXPANSION - Co attributes surge in gross margin to successful cost optimization and manufacturing transition

COST REDUCTION - Operating expenses decreased by 68% yr/yr due to disciplined cost management

REVENUE STABILITY - Revenue remained stable at C$1.66 mln, slightly down from C$1.79 mln in Q3 2024 due to temporary out-of-stock issues

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
C$1.66 mln


Press Release: ID:nCNWCn8DHa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)